Tag : Topical

Latest News

Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Product Candidate When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension

Newsemia
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, announced that...
Pharma / Biotech

Ex vivo (human skin) and in vivo (minipig) permeation of propylene glycol applied as topical crisaborole ointment, 2.

Newsemia
Related Articles Ex vivo (human skin) and in vivo (minipig) permeation of propylene glycol applied as topical crisaborole ointment, 2. Int J Pharm. 2019 Nov...
Pharma / Biotech

Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac.

Newsemia
Related Articles Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac. Int J Pharm. 2019 Nov 09;:118755 Authors:...
Biology

DermBiont Announces Positive Data from Phase 2a Clinical Trial and Start of Phase 2b Clinical Trial for Athlete’s Foot with a Topical Live Biotherapeutic

Newsemia
BOSTON (PRWEB) October 22, 2019 DermBiont, a clinical stage microbiome biotechnology company developing topical live biotherapeutics, has announced that its lead program, DBI-001, met its...
Latest News

Characterization and topical delivery of phenylethyl resorcinol

Newsemia
Zhang, Y; Sil, BC; Kung, C-P; Hadgraft, J; Heinrich, M; Sinko, B; (2019) Characterization and topical delivery of phenylethyl resorcinol. International Journal of Cosmetic Science...
Pharma / Biotech

A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia.

Newsemia
Related Articles A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia. Invest Ophthalmol Vis Sci. 2019...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy